3//SEC Filing
aMoon 2 Fund Limited Partnership 3
Accession 0000899243-20-012309
CIK 0001797336other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:39 PM ET
Size
10.6 KB
Accession
0000899243-20-012309
Insider Transaction Report
Form 3
aMoon 2 Fund Limited Partnership
10% Owner
Holdings
- 1,313,318
Common Stock
Series A Preferred Stock
→ Common Stock (369,231 underlying)Series B Preferred Stock
→ Common Stock (508,924 underlying)
Footnotes (1)
- [F1]The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock shall be automatically converted into one (1) share of common stock upon the closing of the Issuer's initial public offering.
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001744099
Filing Metadata
- Form type
- 3
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 7:39 PM ET
- Size
- 10.6 KB